Skip to main content
Erschienen in:

01.06.2019 | Case report

Ipilimumab

Immune-mediated colitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Johansson PA, et al. Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab. Immunogenetics 71: 433-436, No. 5-6, May 2019. Available from: URL: http://doi.org/10.1007/s00251-019-01108-x - Australia Johansson PA, et al. Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab. Immunogenetics 71: 433-436, No. 5-6, May 2019. Available from: URL: http://​doi.​org/​10.​1007/​s00251-019-01108-x - Australia
Metadaten
Titel
Ipilimumab
Immune-mediated colitis: case report
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63749-2